HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces oxidative stress, DNA strand breaks, and poly(ADP-ribose) polymerase-1 activation in human breast carcinoma cell lines.

Abstract
The formation of reactive oxygen species (ROS) plays a critical role in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced toxicities in mammalian cells since it promotes cell proliferation, growth arrest, and apoptosis. In this study, we investigated whether TCDD induces oxidative stress and DNA damage in human ERalpha(+)/MCF-7 and ERalpha(-)/MDA-MB-231 breast cancer cells and whether this is accompanied by the initiation of DNA repair events. Results indicated that viability of MCF-7 and MDA-MB-231 cells was concentration- and time-dependently reduced by TCDD. Further, we observed significant increases in ROS formation and decreases in intracellular glutathione (GSH) in these two cell lines after TCDD treatment. Overall, the extent of cell death was greater in MCF-7 cells than in MDA-MB-231 cells whereas the magnitude of ROS formation and GSH depletion was greater in MDA-MB-231 cells than in MCF-7 cells. In addition, we observed that at non-cytotoxic concentration (1nM for 5h), TCDD induced decreases in intracellular NAD(P)H and NAD(+) in MCF-7 and MDA-MB-231 cells. These decreases were completely blocked by three types of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. The catalytic activation of PARP-1 in cells treated with TCDD was confirmed by detection of the presence of polymers of ADP-ribose-modified PARP-1 using Western blotting. Moreover, we demonstrated increases in the number of DNA strand breaks in MCF-7 and MDA-MB-231 cells exposed to TCDD as measured by the single-cell gel electrophoresis (Comet) assay. Overall, this evidence confirms that TCDD induces decreases in intracellular NAD(P)H and NAD(+) through PARP-1 activation mediated by formation of DNA strand breaks. In addition, we demonstrated that the extent of oxidative stress and DNA damage was greater in MDA-MB-231 cells than in MCF-7 cells, with a strong correlation to estrogen receptor (ER) status. In conclusions, our findings add further support to the theme that ROS formation is a significant determinant factor in mediating the induction of oxidative DNA damage and repair in human breast cancer cells exposed to TCDD and that the TCDD-induced oxidative stress and DNA damage may, in part, contribute to TCDD-induced carcinogenesis.
AuthorsPo-Hsiung Lin, Chia-Hua Lin, Chuan-Chen Huang, Ming-Chien Chuang, Pinpin Lin
JournalToxicology letters (Toxicol Lett) Vol. 172 Issue 3 Pg. 146-58 (Aug 2007) ISSN: 0378-4274 [Print] Netherlands
PMID17669606 (Publication Type: Journal Article)
Chemical References
  • Benzamides
  • Benzoflavones
  • Coumarins
  • Environmental Pollutants
  • Estrogen Receptor alpha
  • Poly(ADP-ribose) Polymerase Inhibitors
  • Polychlorinated Dibenzodioxins
  • Reactive Oxygen Species
  • Receptors, Aryl Hydrocarbon
  • Tamoxifen
  • NAD
  • afimoxifene
  • NADP
  • alpha-naphthoflavone
  • benzamide
  • 3-aminobenzamide
  • coumarin
  • PARP1 protein, human
  • Poly (ADP-Ribose) Polymerase-1
  • Poly(ADP-ribose) Polymerases
  • Glutathione
Topics
  • Benzamides (pharmacology)
  • Benzoflavones (pharmacology)
  • Breast Neoplasms (genetics, metabolism)
  • Carcinoma (genetics, metabolism)
  • Cell Line, Tumor
  • Cell Survival (drug effects)
  • Coumarins (pharmacology)
  • DNA Breaks
  • Environmental Pollutants (toxicity)
  • Estrogen Receptor alpha (antagonists & inhibitors, metabolism)
  • Glutathione (metabolism)
  • Humans
  • NAD (metabolism)
  • NADP (metabolism)
  • Oxidative Stress
  • Poly (ADP-Ribose) Polymerase-1
  • Poly(ADP-ribose) Polymerase Inhibitors
  • Poly(ADP-ribose) Polymerases (metabolism)
  • Polychlorinated Dibenzodioxins (toxicity)
  • Reactive Oxygen Species (metabolism)
  • Receptors, Aryl Hydrocarbon (antagonists & inhibitors)
  • Tamoxifen (analogs & derivatives, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: